Neonatal renal arterial embolism syndrome

Durante, Dennis; Jones, David F.; Spitzer, Robert J.

doi:10.1016/s0022-3476(76)80614-2

Cited by 20 publications

(3 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Such thrombi may then embolize to the kidneys, causing areas of infarction and increased renin release. A similar phenomenon has been reported in infants with dilatation of the ductus arteriosus [28]. Age-specific percentiles for blood pressure in boys (a) and girls (b) from birth to 12 months of age.…”

Section: Causes Of Hypertension In Neonatessupporting

confidence: 78%

“…Although nuclear scanning has been shown in some studies to demonstrate abnormalities of renal perfusion caused by thromboembolic phenomenon [1,15,16,23,28], in our practice it has had little role in the assessment of infants with hypertension, primarily due to the difficulties in obtaining accurate, interpretable results in this age group. Other studies, including echocardiograms and voiding cystourethrograms, should be obtained as indicated.…”

Section: Clinical Presentation and Diagnostic Approachmentioning

confidence: 99%

See 1 more Smart Citation

Neonatal hypertension: diagnosis and management

Flynn¹

2000

Pediatric Nephrology

161

114

View full text Add to dashboard Cite

Hypertension in the term or preterm neonate may be seen in up to 2% of all infants cared for in the modern neonatal intensive care unit. Although the definition of hypertension in this age group has not been completely standardized, recent studies have provided new normative data that may be used to facilitate identification of such infants. Common causes of hypertension in neonates include thromboembolic events related to umbilical catheterization, congenital problems such as aortic coarctation, structural renal malformations and renovascular disease, as well as acquired renal disease and certain medications. A careful history and physical examination will usually identify the probable cause in most cases without the need for extensive laboratory or radiologic testing. Therapy of neonatal hypertension should be tailored to the severity of the blood pressure elevation, and to the underlying cause of hypertension as appropriate. A wide range of therapeutic agents are now available for management of neonatal hypertension in both the acute and chronic settings. In most cases hypertension will resolve, but some infants may require prolonged treatment.

show abstract

Section: Causes Of Hypertension In Neonatessupporting

confidence: 78%

Section: Clinical Presentation and Diagnostic Approachmentioning

confidence: 99%

Neonatal hypertension: diagnosis and management

Flynn¹

2000

Pediatric Nephrology

161

114

View full text Add to dashboard Cite

show abstract

“…It is postulated that the PDA acts as a nidus for thromboembolisation of the renal artery with subsequent hypertension [41]. However, as many of these infants are treated with indomethacin, it is difficult to delineate whether the hypertension is a consequence of fluid retention or renal hypoperfusion secondary to drug effect.…”

Section: Discussionmentioning

confidence: 99%

Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up

et al. 2007

View full text Add to dashboard Cite

Neonatal hypertension is an uncommon but important complication of intensive care management. The aims of this study were to identify in neonates with hypertension: antenatal and postnatal risk factors; aldosterone and renin levels; and report on outcome in early infancy. The study involved a retrospective review of neonates diagnosed with systemic hypertension from January 2001 to December 2005. Demographic data, risk factors, laboratory investigation, and follow-up data at 3-6 months of age were collected. Of the 2,572 newborn infants included, 34 (1.3%) had neonatal hypertension. Gestational age and birth weight and length were significantly lower in infants with hypertension. The median postnatal age at diagnosis of systemic hypertension was 5.0 days. Antenatal steroid administration, maternal hypertension, umbilical arterial catheter, postnatal acute renal failure, patent ductus arteriosus, indomethacin treatment and chronic lung disease were associated with the development of neonatal hypertension [odds ratios (OR) 8.7, 3.8, 10.0, 51.8, 5.9, 5.7 and 7.7, respectively]. Elevated aldosterone and renin levels occurred in 60% and 33% but had normalised in the majority by 6 months of age. The majority of infants do not require treatment for hypertension by 6 months of age.

show abstract

Renal Cystic Disease and Vascular Lesions of the Adrenal and Kidney

Liu

Leung

2018

Rickham's Neonatal Surgery

View full text Add to dashboard Cite

Neonatal renal arterial embolism syndrome

Cited by 20 publications

References 7 publications

Neonatal hypertension: diagnosis and management

Neonatal hypertension: diagnosis and management

Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up

Renal Cystic Disease and Vascular Lesions of the Adrenal and Kidney

Contact Info

Product

Resources

About